Abstract #3042

Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in the Diagnosis of Hepatocellular Carcinoma in Patients with Impaired Liver Function

Eun-Suk Cho¹, Jeong-Sik Yu¹

¹Radiology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of

Gadoxetic acid-enhanced MRI improves detection of hepatocellular carcinoma (HCC). However, since the degree of liver enhancement in hepatobiliary phase is known to be lower in patients with chronic liver dysfunction, diagnostic value of hepatobiliary phase imaging of Gadoxetic acid-enhanced MRI might be expected to be lower in the diagnosis of HCC in patients with impaired liver function. Therefore, we tried to evaluate the value of hepatobiliary phase of gadoxetic acid-enhanced MRI in the diagnosis of HCC in patients with impaired liver function.